Primary Biliary Cholangitis Clinical Trials

A listing of 5 Primary Biliary Cholangitis clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Conditions

Primary Biliary Cholangitis

1 - 5 of 5

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

There are currently 5 active clinical trials seeking participants for Primary Biliary Cholangitis research studies. The states with the highest number of trials for Primary Biliary Cholangitis participants are Florida, California, Texas and New York.

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Chronic Cough Clinical Study

Recruiting

We are evaluating an investigational treatment to see if it may help people dealing with chronic cough.
Eligible participants will receive study-related medical care at no cost. You may be compensated for study-related travel and time. Health insurance is not required. If you qualify, you may receive:
Payment up to $1500, which varies by study.

Conditions:

Cough

Chronic Cough

Asthma

Allergic Asthma

Sinusitis

Learn More

Featured Trial

Healthy Volunteer Trials

Recruiting

Healthy trials near you are looking for participants to help push medical research forward. Click through to learn more!

Conditions:

Healthy

Learn More

Featured Trial

Healthy Volunteer Clinical Studies

Recruiting

Find a study looking for volunteers at a study site near you! Some trials offer compensation for time and travel. Click through to learn more about study opportunities.

Conditions:

Healthy

Healthy Volunteers

Learn More

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

NCT06051617

Recruiting

To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.

Gender:

All

Ages:

Between 18 years and 75 years

Trial Updated:

06/14/2024

Locations: Om Research LLC, Lancaster, California +39 locations

Om Research LLC, Lancaster, California

SCPMG/ Kaise Permanente Los Angeles Medical Center, Los Angeles, California

California Liver Research Center, Pasadena, California

University of California, Davis Medical Center (Study Visits), Sacramento, California

California Pacific Medical Center - Sutter Pacific Medical Foundation, San Francisco, California

Connie Frank Transplant center at UCSF, San Francisco, California

Covenant Metabolic Specialists, LLC, Fort Myers, Florida

Florida Research Institute, LLC, Lakewood Ranch, Florida

University of Miami Hospital, Miami, Florida

Covenant Metabolic Specialists, LLC, Sarasota, Florida

Piedmont Atlanta Hospital/Piedmont Transplant Institute, Atlanta, Georgia

University of Chicago Medical Center, Chicago, Illinois

University of Iowa Hospitals & Clinics, Iowa City, Iowa

University of Louisville, Louisville, Kentucky

University Healthcare System East Jefferson General Hospital Campus, Metairie, Louisiana

Ochsner Clinic Foundation, New Orleans, Louisiana

Mercy Medical Center, Baltimore, Maryland

Beth Israel Deconess Medical Center, Boston, Massachusetts

Northwell Health Center for Liver Disease and Transplantation, Manhasset, New York

NYU Langone Health, New York, New York

Mount Sinai, New York, New York

Wake Forest Baptist Medical Center, Winston-Salem, North Carolina

University Hospitals Cleveland Medical Center, Cleveland, Ohio

UPMC Center for Liver Diseases, Pittsburgh, Pennsylvania

The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas

University of Texas Southwestern Medical Center, Professional Office Building One, Dallas, Texas

Pinnacle Clinical Research, LLC, San Antonio, Texas

Medstar Health Research Institute/MedStar Georgetown Transplant, Fairfax, Virginia

Mayview Hospital LLC d/b/a Bon Secours Liver Institute of Hampton Roads, Newport News, Virginia

VCU Health Clinical Research Services Unit (CRSU), Richmond, Virginia

Liver Institute Northwest, Seattle, Washington

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do

Pusan National University Hospital, Busan, Not set

Kyungpook National University Hospital, Daegu, Not set

Mersin Universitesi Tip Fakultesi Hastanesi, Mersin, Yenisehir

Uludag University Medical Faculty Gorkule Kampusu, Bursa, Not set

Marmara University Pendik Training and Research Hospital, Istanbul, Not set

Ege University, Department of Gastroenterology, İzmir, Not set

Kocaeli University Medical Faculty Hospital, Kocaeli, Not set

Rize Recep Tayyip Erdogan University Training and Research Hospital, Rize, Not set

Conditions: Primary Biliary Cholangitis

Learn More ›

IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA)

NCT06060665

Recruiting

To Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects with Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA)

Gender:

All

Ages:

Between 18 years and 75 years

Trial Updated:

06/14/2024

Locations: The Institute for Liver Health II dba Arizona Liver Health, Chandler, Arizona +28 locations

The Institute for Liver Health II dba Arizona Liver Health, Chandler, Arizona

California Liver Reasearch Institute, Pasadena, California

California Liver Research Institute, Pasadena, California

Stanford Medicine Outpatient Center, Redwood City, California

University of California, Davis Medical Center (Study Visits), Sacramento, California

University of California, Davis Medical Center, Sacramento, California

California Pacific Medical Center - Sutter Pacific Medical Foundation, San Francisco, California

University of Colorado Anschultz Medical Campus, Aurora, Colorado

South Denver Gastroenterology, PC, Englewood, Colorado

Covenant Metabolic Specialists, LLC, Fort Myers, Florida

Schiff Center for Liver Diseases/University of Miami, Miami, Florida

Covenant Metabolic Specialists, LLC, Sarasota, Florida

Digestive Healthcare of Georgia, P.C., Atlanta, Georgia

Tulane Medical Center, New Orleans, Louisiana

Louisiana Research Center, LLC, Shreveport, Louisiana

Mercy Medical Center, Baltimore, Maryland

Massachusetts General Hospital, Boston, Massachusetts

Beth Israel Deconess Medical Center, Boston, Massachusetts

Henry Ford Columbus Center, Novi, Michigan

Kansas City Research Institute, Kansas City, Missouri

NYU Langone Health, New York, New York

The New York-Presbyterian Hospital, New York, New York

University of Rochester Medical Center, Rochester, New York

UPMC Center for Liver Diseases, Pittsburgh, Pennsylvania

Gastro One, Cordova, Tennessee

The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas

American Research Corporation, San Antonio, Texas

Mayview Hospital LLC d/b/a Bon Secours Liver Institute of Hampton Roads, Newport News, Virginia

Velocity Clinical Research, Seattle (Pharmacy), Seattle, Washington

Conditions: Primary Biliary Cholangitis

Learn More ›

A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis

NCT05050136

Recruiting

The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Biliary Cholangitis (PBC), and to assess the possible impact on the disease progression of PBC.

Gender:

All

Ages:

18 years and above

Trial Updated:

04/23/2024

Locations: Southern California Research Center, Coronado, California +66 locations

Southern California Research Center, Coronado, California

Science 37, Inc (Remote-homebased Telemedicine), Culver City, California

Cedars Sinai Medical Center, Los Angeles, California

University of Colorado, Aurora, Colorado

Covenant Metabolic Specialists, Fort Myers, Florida

UF Hepatology Research at CTRB, Gainesville, Florida

UF Health Gastroenterology- Emerson, Jacksonville, Florida

IHS Health, Kissimmee, Florida

Schiff Center for Liver Diseases, Miami, Florida

Advanced Research Institute, Inc, New Port Richey, Florida

Covenant Research and Clinics, LLC, Sarasota, Florida

Tampa General Hospital, Tampa, Florida

Southeast Clinical Research Center, Dalton, Georgia

Northwestern University, Chicago, Illinois

Loyola University Health System - Loyola Outpatient Center, Maywood, Illinois

University of Iowa Hospitals & Clinics, Iowa City, Iowa

Ochsner Clinic Foundation-Baton Rouge, Baton Rouge, Louisiana

LSU Health Science Center Shreveport, Shreveport, Louisiana

Beth Israel Deaconess, Boston, Massachusetts

Mayo Clinic, Rochester, Minnesota

Jackson Liver and GI Specialists, Jackson, Mississippi

CHI Health Clinic (Alegent Creighton Clinic)- Gastroenterology-Bergan, Omaha, Nebraska

Cleveland Clinic - Main Campus, Cleveland, Ohio

Einstein Healthcare Network - Einstein Medical Center, Philadelphia, Pennsylvania

Methodist Le Bonheur Healthcare, Memphis, Tennessee

Galen Medical Group, P.C, Tennessee, Tennessee

Amel Med LLC, Austin, Texas

Soma Clinical Trials, Denison, Texas

Liver Associates of Texas, Houston, Texas

Impact Research, Waco, Texas

University of Utah Health Care, Salt Lake City, Utah

MedStar Health Research Institute, Fairfax, Virginia

Bon Secours Liver Institute of Hampton Roads Mary Immaculate Hospital, Newport News, Virginia

Bon Secours Richmond Community Hospital LLC d/b/a Bon Secours Liver Institute of Richmond, Richmond, Virginia

Liver Institute Northwest, Seattle, Washington

CHU Grenoble - Hôpital MICHALLON, Grenoble, Not set

Hopital Claude Huriez-Digestive system disease clinic, Lille, Not set

CHU de NICE- Hospital L'Archet 2, Nice, Not set

Hospital Saint Antoine, Paris, Not set

Nouvel Hospital Civil, Strasbourg, Not set

Hospital Paul Brousse- APHP, Villejuif, Not set

Klinikum Chemnitz gGmbH, Chemnitz, Not set

Universitätsklinikum Frankfurt am Main, Frankfurt, Not set

Medizinische Hochschule Hannover (MHH), Hanover, Not set

Universitätsklinikum Schleswig-Holstein, Kiel, Not set

University Hospital Munster, Münster, Not set

University Hospital Tübingen Medical clinic, Tubingen, Not set

St. Josefs-Hospital Wiesbaden, Wiesbaden, Not set

Hillel Yaffe Medical Center, Hadera, Not set

Rambam Medical Center, Haifa, Not set

Carmel Medical Center, Haifa, Not set

Shaare Zedek Medical Center, Jerusalem, Not set

Hadassah Medical Center - Ein Karem, Liver Institute Kiryat Hadassah POB 12000, Jerusalem, Not set

Galilee Medical Center, Nahariyya, Not set

Rabin Medical Center, Petach Tikva, Not set

Sheba Medical Center, Ramat Gan, Not set

The Tel Aviv Sourasky Medical Center, Tel Aviv, Not set

Universita Politecnica delle Marche- Ospedali Riuniti, Ancona, Not set

Fondazione Ca Granda, Milano, Not set

ASST Grande Ospedale Metropolitano Niguarda, Milano, Not set

Fondazione IRCCS San Gerardo dei Tintori, Monza, Not set

Azienda Ospedale-Università di Padova, Padova, Not set

Azienda Ospedaliero Universitaria Pisana (AOUP), Pisa, Not set

Istituto Clinico Humanitas, Rozzano, Not set

Belfast Health & Social Care Trust (BHSCT) Royal Victoria Hospital, Belfast, Not set

King's College Hospital NHS Foundation Trust, London, Not set

Nottingham University Hospitals NHS Trust, Nottingham, Not set

Conditions: Primary Biliary Cholangitis, PBC

Learn More ›

Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

NCT06247735

Recruiting

Study to investigate the efficacy and safety of two doses of K-808 (pemafribate) in subjects with PBC.

Gender:

All

Ages:

18 years and above

Trial Updated:

01/30/2024

Locations: Springfield Clinic, Springfield, Illinois +1 locations

Conditions: Primary Biliary Cholangitis

Learn More ›

An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

NCT04950764

Recruiting

The Effect of Hepatic Impairment on The Pharmacokinetics of Seladelpar: An Open-Label Study Following Oral Dosing of Seladelpar to Subjects with Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

Gender:

All

Ages:

Between 18 years and 80 years

Trial Updated:

01/26/2024

Locations: The Institute of Liver Health dba Arizona Liver Health, Chandler, Arizona +17 locations